(Q30438009)

English

Challenges and opportunities for medications development in alcoholism: an international perspective on collaborations between academia and industry

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Challenges and opportunities for medications development in alcoholism: an international perspective on collaborations between academia and industry (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

0 references

1 reference

based on heuristic

inferred from title

author name string

Bankole A Johnson

1

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Karl Mann

2

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Mark L Willenbring

3

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Raye Z Litten

4

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Robert M Swift

5

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Otto M Lesch

6

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Mats Berglund

7

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 August 2005

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Alcoholism: Clinical and Experimental Research

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

29

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

1528-1540

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Clinical research in the United States at a crossroads: proposal for a novel public-private partnership to establish a national clinical research enterprise

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000174690.63787.FC

21 January 2018

Recovery from DSM-IV alcohol dependence: United States, 2001-2002

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000174690.63787.FC

21 January 2018

Evidence for addiction-like behavior in the rat.

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000174690.63787.FC

21 January 2018

Progress in the development of topiramate for treating alcohol dependence: from a hypothesis to a proof-of-concept study

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000174690.63787.FC

21 January 2018

Neuropharmacological treatments for alcoholism: scientific basis and clinical findings

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000174690.63787.FC

21 January 2018

Oral topiramate reduces the consequences of drinking and improves the quality of life of alcohol-dependent individuals: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000174690.63787.FC

21 January 2018

Age of onset as a discriminator between alcoholic subtypes in a treatment-seeking outpatient population.

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000174690.63787.FC

21 January 2018

Effects of isradipine on cocaine-induced subjective mood

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000174690.63787.FC

21 January 2018

Dose-ranging kinetics and behavioral pharmacology of naltrexone and acamprosate, both alone and combined, in alcohol-dependent subjects

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000174690.63787.FC

21 January 2018

Oral topiramate for treatment of alcohol dependence: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000174690.63787.FC

21 January 2018

Pharmacological relapse prevention of alcoholism: clinical predictors of outcome

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000174690.63787.FC

21 January 2018

Self-report and biochemical measures of alcohol consumption

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000174690.63787.FC

21 January 2018

Development of medications for alcohol use disorders: recent advances and ongoing challenges

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000174690.63787.FC

21 January 2018

Challenges to medications development in treating alcohol dependence: an international perspective

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000174690.63787.FC

21 January 2018

Physicians’ opinions about medications to treat alcoholism

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000174690.63787.FC

21 January 2018

A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000174690.63787.FC

21 January 2018

Rats on the grog: novel pharmacotherapies for alcohol craving.

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000174690.63787.FC

21 January 2018

Contemporary addiction treatment: a review of systems problems for adults and adolescents

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000174690.63787.FC

21 January 2018

Naltrexone decreases craving and alcohol self-administration in alcohol-dependent subjects and activates the hypothalamo-pituitary-adrenocortical axis.

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000174690.63787.FC

21 January 2018

A functional polymorphism of the mu-opioid receptor gene is associated with naltrexone response in alcohol-dependent patients

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000174690.63787.FC

21 January 2018

A polymorphism of the mu-opioid receptor gene (OPRM1) and sensitivity to the effects of alcohol in humans

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000174690.63787.FC

21 January 2018

Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000174690.63787.FC

21 January 2018

Alcoholic patients' experience and attitudes on pharmacotherapy for alcoholism.

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000174690.63787.FC

21 January 2018

Testing combined pharmacotherapies and behavioral interventions in alcohol dependence: rationale and methods

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000174690.63787.FC

21 January 2018

Drug seeking becomes compulsive after prolonged cocaine self-administration.

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000174690.63787.FC

21 January 2018

Beliefs about evidence-based practices in addiction treatment: a survey of Veterans Administration program leaders

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000174690.63787.FC

21 January 2018

Alcoholic subtypes: are two sufficient?

1 reference

https://api.crossref.org/works/10.1097%2F01.ALC.0000174690.63787.FC

21 January 2018

Identifiers

10.1097/01.ALC.0000174690.63787.FC

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30438009&oldid=1606120425"